Cargando…
Crosstalk between glucocorticoid and mineralocorticoid receptors boosts glucocorticoid-induced killing of multiple myeloma cells
The glucocorticoid receptor (GR) is a crucial drug target in multiple myeloma as its activation with glucocorticoids effectively triggers myeloma cell death. However, as high-dose glucocorticoids are also associated with deleterious side effects, novel approaches are urgently needed to improve GR ac...
Autores principales: | Clarisse, Dorien, Prekovic, Stefan, Vlummens, Philip, Staessens, Eleni, Van Wesemael, Karlien, Thommis, Jonathan, Fijalkowska, Daria, Acke, Guillaume, Zwart, Wilbert, Beck, Ilse M., Offner, Fritz, De Bosscher, Karolien |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10425521/ https://www.ncbi.nlm.nih.gov/pubmed/37578563 http://dx.doi.org/10.1007/s00018-023-04900-x |
Ejemplares similares
-
Coregulator profiling of the glucocorticoid receptor in lymphoid malignancies
por: Clarisse, Dorien, et al.
Publicado: (2017) -
Effect of combining glucocorticoids with Compound A on glucocorticoid receptor responsiveness in lymphoid malignancies
por: Clarisse, Dorien, et al.
Publicado: (2018) -
How the glucocorticoid receptor contributes to platinum-based therapy resistance in solid cancer
por: Clarisse, Dorien, et al.
Publicado: (2021) -
Selective glucocorticoid receptor-activating adjuvant therapy in cancer treatments
por: Sundahl, Nora, et al.
Publicado: (2016) -
ZBTB32 performs crosstalk with the glucocorticoid receptor and is crucial in glucocorticoid responses to starvation
por: Van Wyngene, Lise, et al.
Publicado: (2021)